English
This article is from Indian Journal of Endocrinology and Metabolism , volume 16 . Abstract Objective:: The objective of the present study was to prospectively evaluate the results of laparoscopic ileal interposition (II) with diverted sleeve gastrectomy (DSG) for control of type 2 diabetes mellitus (T2DM) and related metabolic abnormalities. Materials and Methods:: All patients underwent II +DSG. They had T2DM ≥5 years with poor glycemic control despite adequate dosage of oral hypoglycemic agents (OHAs) and/or insulin. The primary outcome was remission of diabetes (HbA1C <6.5% without OHAs/insulin), and secondary outcomes were reduction in antidiabetic agent requirement and components of metabolic syndrome. Results:: We report the preliminary postoperative follow-up data of 13.1 ± 5.3 months (range: 3–26 months). There were 32 patients (Male: female = 21:11) with mean age of 48.7 ± 7.8 (range, 34-66 years), duration of diabetes of 13.1 ± 5.8 years (range, 5-30 years), and preoperative body mass index of 29.1 ± 6.9 kg/m2 (range: 22.4-39.5 kg/m2). Sixteen patients (50%) had hypertension, while dyslipidemia and microalbuminuria were present in 12 patients (39%) each. Twenty two patien
Sign in with your free account to read, download EPUBs or listen.
Ebook · Ileal Interposition with Diverted sleeve gastrectomy for treatment of Type 2 diabetes. · Kota, Sunil Kumar, Ugale, Surendra, Gupta, Neeraj, Krishna, S.V.S., Modi, K.D. · Internet Archive